CLINICAL_TRIALS
withdrawal
· 2017-05-15
Clinical Trial Update: Evaluation of the Pharmacokinetic Profile, Pharmacodynamic Effects, Acceptability and Tolerability of an Oral Amiodarone Solution of 15 mg / mL in Children With Supra Ventricular Tachycardia [Phase 2]
Summary
A Phase 2 pediatric trial evaluating the pharmacokinetic, pharmacodynamic, acceptability, and tolerability of an oral amiodarone solution in children with supra…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Supraventricular Tachycardia | Phase 2 | Status: WITHDRAWN